Fresh Tracks Therapeutics, Inc. (FRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.750
+0.010 (1.35%)
Dec 26, 2024, 4:00 PM EST
Fresh Tracks Therapeutics Company Description
Fresh Tracks Therapeutics, Inc. does not have significant operations.
Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States.
Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Fresh Tracks Therapeutics, Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Albert Marchio |
Contact Details
Address: 2000 Central Avenue Boulder, Delaware 80301 United States | |
| Phone | 720 505 4755 |
| Website | ir.frtx.com |
Stock Details
| Ticker Symbol | FRTX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US10802T2042 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Albert Nicholas Marchio II | Chief Executive Officer, Chief Financial Officer, Secretary and Chairman |
| Aron Aizenstat M.B.A., P.M.P. | Vice President of Corporate Development and Operations |
| Aaron Fox-Collis CPA | Vice President of Finance and Chief Accounting Officer |
| Sue Fattor | Head of Human Resource |
| Dr. James S. McElvain Ph.D. | Interim Head of CMC Development |